All components of the MS, such as fasting glucose, lipid profile, waist circumference and blood pressure, were significantly worse in the GHD patients, confirming that among patients with obesity and overweight, those with GHD have a higher cardiovascular risk than obese and overweight individuals with preserved GH secretory capacity. This evidence concerns the gene GH1 and obesity disorder.